Top 50 Dna Data Storage in Europe

Biomemory develops DNA Drives that utilize molecular engineering to store data at a density one million times greater than traditional SSDs or magnetic tape. This technology addresses the need for long-term, energy-efficient data storage solutions with minimal environmental impact, ensuring data durability for thousands of years.

The startup has developed a genome-analysis platform that facilitates the acquisition, analysis, and storage of genomic data without the need for repeated sequencing of the same genome for different tests. This technology enables healthcare providers to efficiently manage genetic data and deliver precise DNA sequencing services, enhancing the overall effectiveness of genomic research and patient care.

This startup offers next-day plasmid sequencing services with integrated bioinformatics analysis. Their platform provides high-throughput, quality, and cost-effective sequencing, supporting bioscience research globally.

Tailwind Biotech provides artificial DNA design services using proprietary artificial intelligence to optimize DNA sequences for bioproduction companies. This technology enhances gene expression and reduces development costs, enabling more efficient and effective genetic engineering processes.

The startup operates a personal health and genomic data-sharing platform that connects users with researchers, enabling participation in studies on common and rare diseases. By allowing individuals to control their data and opt into research, the platform facilitates the collection of dynamic health and genetic datasets for personalized medicine.

Camena Bioscience develops the gSynth® platform, a TdT-free enzymatic DNA synthesis technology that enables the high-throughput production of synthetic genes of any sequence, length, and complexity. This technology addresses the limitations of traditional DNA synthesis methods, which struggle to produce long, accurate synthetic DNA at scale, thereby facilitating advancements in personalized mRNA vaccines, cell and gene therapies, and CRISPR applications.

The startup has developed a digital diagnostics platform that utilizes artificial intelligence for genetic analysis and clinical decision support, enhancing the traceability and interoperability of bioinformatics data. This technology enables researchers and clinicians to efficiently access and reuse critical information, thereby expediting the diagnosis process for various diseases.

The startup offers a microbial bioinformatics and data management platform that enables researchers to analyze and interpret microbial genomic data effectively. By providing software licensing, consulting, and training, the platform enhances the understanding of microbial genomes and their biological functions, facilitating advancements in genomics research.

DnaNudge utilizes DNA analysis and lifestyle data to provide personalized nutritional guidance, helping consumers make healthier food choices based on their genetic predispositions to conditions like obesity and diabetes. The company also offers a rapid, lab-free CovidNudge RT-PCR test that accurately detects COVID-19 and other viruses in under an hour, facilitating timely diagnosis without laboratory dependency.

Evonetix is developing a desktop platform that synthesizes gene-length DNA with high accuracy and scalability using a novel approach to DNA synthesis. This technology provides researchers with rapid access to precise genetic material, addressing the limitations of current gene synthesis methods that hinder innovation in healthcare and biotechnology.

The startup develops a DNA integration platform that enhances the engineering of cell lines for gene and cell therapies, specifically targeting the production of recombinant adeno-associated virus vectors. By improving viral vector yield and efficacy, the company enables biopharmaceutical firms to produce more effective therapies for serious diseases.

TileDB provides a unified platform for managing and analyzing both structured and unstructured scientific data, enabling teams to catalog, collaborate, and perform large-scale analyses without data silos. This solution enhances the efficiency of drug and target discovery by centralizing diverse data types and facilitating secure collaboration across research teams.

Code Biotherapeutics is developing a multivalent synthetic DNA delivery platform, 3DNA®, to enhance the precision and bioavailability of non-viral gene therapies for life-threatening diseases. The company focuses on overcoming challenges such as dose-related toxicity and off-target effects, with a primary research emphasis on Duchenne Muscular Dystrophy.

Enhanc3D Genomics utilizes its GenLink3D platform to analyze the 3D organization of DNA, focusing on the impact of genetic variations in non-coding regions on disease progression. This approach enables the identification of new biomarkers and treatment targets for complex conditions such as cancer, aging, and autoimmune diseases.

The startup utilizes a biosynthetic mapping approach combined with experimental data analysis to identify microbial genes that can produce novel drug compounds. This enables pharmaceutical companies and research institutions to access unique molecules with potential new mechanisms for drug development.

Arweave provides a decentralized data storage solution using blockchain technology, enabling permanent and tamper-proof retention of information. This addresses the need for reliable long-term data preservation and supports the development of decentralized web applications.

Seqera provides a platform that enables scientists to build, run, and analyze bioinformatics pipelines using open-source tools like Nextflow, facilitating scalable and reproducible workflows across various computing environments. By integrating data, compute, and security, Seqera addresses the challenges of managing complex genomic data analysis, significantly improving research productivity and collaboration.

Dwinity is a Web3 operating system that utilizes decentralized storage and predictive AI to enable users to securely manage and control their sensitive data as a digital twin. This approach addresses the limitations of centralized data management by allowing individuals to transform their personal data into valuable assets while maintaining privacy and ownership.

Provides enterprise blockchain-based data security solutions that enable organizations to encrypt, fragment, and distribute data across user-owned multi-cloud environments. This approach protects against cyber threats, ensures business continuity, and maintains data integrity through blockchain-powered proof of record, addressing challenges in data sovereignty and secure collaboration.

The startup develops targeted cancer drugs that focus on novel DNA replication stress pathways activated in tumors. By targeting key molecular mechanisms involved in DNA replication stress, the company aims to provide first-in-class therapeutic options for effective cancer treatment.

SökerData provides curated health datasets that represent diverse DNA differences, enabling accurate biomarker visualization for early drug discovery and clinical trials. The company addresses the lack of unbiased data from minority populations, enhancing the reliability of clinical outcomes and treatment responses.

Constructive.Bio utilizes a dual-technology platform that combines de novo genome synthesis and engineered translation to create programmable biomolecules with high fidelity. This approach addresses the limitations of traditional biomanufacturing by enabling the production of customized bioproducts, including phage-resistant strains and next-generation therapeutics.

Perseus Biomics utilizes its DynaMAP™ technology, which employs fluorocoding and optical mapping for strain-specific taxonomic profiling without amplification or library preparation, to deliver rapid and precise microbiome analysis. This approach addresses the limitations of traditional sequencing methods by providing high-resolution microbiome profiles in just a few hours, enhancing both accuracy and cost-efficiency for researchers and clinicians.

Ovation provides a cloud-based laboratory information management system (LIMS) tailored for molecular diagnostic labs, facilitating lab workflows, sample tracking, and document management. The platform enhances clinical diagnostics by enabling efficient data collection and organization, which supports informed decision-making in drug discovery and patient stratification.

Nanovery is developing liquid nanorobots that detect DNA and RNA biomarkers in liquid samples, providing precise quantification of nucleic acids. This technology addresses the challenges of traditional nucleic acid testing by simplifying workflows and reducing time and costs associated with biomarker analysis.

NU offers a modular multi-omics digital health platform that integrates genetic, epigenetic, and microbiome data to generate personalized health insights and actionable recommendations. This technology enables health practitioners to efficiently manage client data and create tailored health plans, ultimately enhancing client outcomes and optimizing aging processes.

This startup develops DNA technology tailored for synthetic biology applications, providing high-throughput libraries and custom DNA sequences for genome construction and data storage. Their services enable researchers and companies to efficiently create and manipulate DNA without facing economic or time constraints.

The startup operates a synthetic biology platform that designs and manufactures biomedicines by creating product-specific libraries of synthetic genetic parts. By utilizing bioinformatic analysis of genome-scale data, the company enables clients to engineer novel biomolecules tailored to specific therapeutic properties.

NAGENE specializes in the rapid synthesis of custom DNA sequences, utilizing a GMP-compliant, in-house process that ensures high-quality production within an average turnaround time of five days. This capability addresses the urgent need for reliable gene synthesis in pharmaceutical research and development, particularly for mRNA vaccines and cancer treatments.

Syngens AS has developed an AI-powered DNA Design Platform that enables precise and predictable DNA engineering for biomanufacturing applications. By optimizing gene expression and constructing novel biological pathways, the platform addresses the limitations of scalability and engineering precision in current biological methods, significantly reducing trial-and-error in experimental processes.

Serenity Shield provides a blockchain-based StrongBox DApp for the secure storage, management, and recovery of sensitive data, ensuring users maintain complete ownership and control over their information. The platform addresses the risks of data loss and unauthorized access by offering a decentralized solution with built-in inheritance protocols for seamless data transfer.

The startup provides permanent blockchain storage that utilizes end-to-end encryption to secure files and messages on-chain, ensuring user privacy and data ownership. This solution enables individuals and web3 startups to store and collaborate on sensitive information in a decentralized manner, protecting against data exploitation.

Genomes.io provides a secure platform for individuals to upload their genomic data and retain ownership while enabling pharmaceutical and research organizations to access this data for studies through a blockchain-based consent system. This approach addresses the lack of transparency and equitable compensation in the genomics market, allowing users to monetize their DNA data while maintaining privacy and control.

TransferChain utilizes client-side encryption to ensure that user documents remain private and secure while being backed up, synced, and shared across multiple devices. This technology prevents unauthorized access, including by TransferChain itself, addressing the need for secure cloud storage without compromising user privacy.

Officinae Bio provides a biological design and manufacturing platform that specializes in synthesizing complex DNA constructs and RNA transcripts, enabling the creation of sophisticated genetic variant libraries. This technology supports researchers in developing programmable therapies and precise genetic solutions to advance their scientific inquiries.

Provides an open-source data infrastructure for biological research, enabling seamless management of large-scale datasets and metadata through a unified API. It tracks data lineage across notebooks, scripts, and pipelines while integrating workflow managers like Redun and Nextflow, ensuring reproducibility and transparency. The platform standardizes, validates, and annotates biological data with minimal code, facilitating collaboration between dry and wet labs and supporting scalable learning through API-first access.

GenomSys provides a cloud-based genomic data analysis platform utilizing the ISO/IEC 23092 MPEG-G standard, enabling rapid processing and transmission of genomic files with up to 77% reduced file sizes. This technology facilitates faster time-to-market for genomic applications by streamlining workflows and enhancing data accessibility for healthcare professionals.

CESS develops a blockchain-based decentralized cloud storage system that provides customizable data management solutions while ensuring user data privacy and ownership protection. The platform addresses the need for secure, scalable storage infrastructure in Web3 applications, enabling efficient data retrieval and compliance with data sovereignty regulations.

REM Analytics provides microbiome analysis services, offering detailed insights into the composition and function of microbial communities. Their analysis helps researchers and companies understand the impact of microbes on health, agriculture, and the environment.

DATABIOMIX offers end-to-end microbiota analysis and microbial genomics services, providing researchers and healthcare providers with comprehensive reports and expert interpretation. Their AI-based platform facilitates microbiota biomarker discovery for personalized medicine and the development of microbiome-derived companion diagnostics.

SimplexDNA AG utilizes environmental DNA (eDNA) analysis to identify and quantify species present in various ecosystems through genetic sequencing techniques. This service provides researchers and conservationists with critical data for monitoring biodiversity and assessing ecosystem health, addressing the lack of accurate species identification in complex environments.

The startup provides plasmid sequencing services using nanopore technology to ensure high-quality results with rapid turnaround times. Their offerings include validating plasmid insert orientation and backbone integrity, which helps researchers in academia and the pharmaceutical industry avoid contamination and primer issues.

Gimel ID develops a secure ID wallet that utilizes DNA biometrics to provide proof of personhood in compliance with the EU's eIDAS 2.0 regulations. This technology addresses the challenge of verifying individual identities in an increasingly digital landscape, ensuring data privacy and fostering health equity.

ADLIN Science provides a collaborative digital workspace for researchers to structure, manage, and analyze multi-omics data while ensuring data sovereignty and compliance with regulations. The platform enhances research efficiency by facilitating interdisciplinary collaboration and enabling the generation of FAIR-compliant datasets throughout the research lifecycle.

ScienceMachine develops AI systems that automate the analysis of complex biological data, enabling scientists to quickly derive insights from lab-collected datasets like RNA-seq. This technology accelerates drug development for biotech and pharmaceutical companies by streamlining data processing and ensuring no valuable scientific information is overlooked.

Develops customizable nanowire biosensor platforms that enable ultra-sensitive detection of low-abundance biomolecules, improving diagnostic accuracy for diseases. These platforms support next-generation DNA sequencing and molecular biomarker identification, offering up to 8X more genetic information in reduced time and cost compared to current methods.

intoDNA provides an end-to-end service for DNA break detection using its proprietary STRIDE™ technology, which quantitatively measures free DNA ends and identifies specific types of DNA damage in various biological materials. This technology enables precision biomarker discovery, facilitating informed decision-making in targeted therapeutics development and patient selection.

XGenomes develops DNA sequencing technologies that utilize optical super-resolution imaging and machine learning to monitor health, detect early disease signals, and track interventions throughout an individual's life. Their platform addresses high error rates and complex workflows in existing sequencing methods, providing a streamlined and cost-effective solution for continuous health monitoring.

The startup develops sensitive sample preparation products for nucleic acid extraction, specifically designed for life science research, in vitro diagnostics, and aquaculture applications. Their technology enables efficient extraction of high-integrity nucleic acids, facilitating accurate downstream analyses for clinicians and researchers.

Sophgena provides genetic analysis and DNA testing services, utilizing liquid biopsies and long-read sequencing to deliver personalized medical insights. The company enables individuals to understand their genetic predispositions, facilitating early detection and tailored treatment options for congenital and acquired diseases.